Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05579808
Other study ID # 3741
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2021
Est. completion date September 1, 2021

Study information

Verified date October 2022
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Lumbar epidural analgesia is the most used method for reducing labour pain, but its impact on the duration of the second stage of labour and on neonatal and maternal outcomes remains debated. The aim was of the study is to examine whether epidural analgesia affects the course and the outcomes of labour among patients divided according to the Robson-10 group classification system. Patients of Robson's classes 1, 2a, 3, and 4a were divided into either the epidural analgesia group or the non-epidural analgesia group. A propensity score matching analysis was performed to balance intergroup differences. The primary goal was to analyse the duration of the second stage of labour. The secondary goals were to evaluate neonatal and maternal outcomes.


Description:

Lumbar epidural analgesia (EA) is the recognized gold standard in labour pain control [1]. However, with data available to both support and refute a relationship between EA and a significant prolongation of the second stage of labour [1-4] (especially with low-dose anaesthetic protocols), its role is still controversial [5,6] . The second stage of labour is described as the period between complete cervical dilatation and the delivery of the baby. In 2014 the American College of Obstetricians and Gynecologists (ACOG) defined the normal duration of the second stage of labour as up to 2 hours in multiparous women and 3 hours in nulliparous ones [7]. However, as long as progress is being documented [7-9], newer recommendations propose longer durations based on individual factors [10,11] such as parity, maternal age [2] and body mass index (BMI) [12], hypertension [13], foetal weight and position [14], maternal position [15], oxytocin augmentation [2], and EA [16]. This study's attention on this phase of labour is strictly related to the potential impact of EA on foetal and maternal outcomes, and obstetric decision making [17-19]. In the literature, some papers report no detrimental foetal outcomes in cases involving a longer duration [3,20,21], while others show increased rates of maternal morbidity (third- or fourth-degree perineal lacerations, postpartum haemorrhage, and chorioamnionitis) [17,22] and Caesarean sections (CS), with labour dystocia as one of leading indications [19]. In order to investigate the effects of EA on labour effectively a propensity score matching seems appropriate. Propensity score matching is a statistical method for collecting data retrospectively that minimizes the selective biases that can arise from patients' backgrounds. Many studies have reported that propensity score matching produces results similar to RCTs despite its retrospective nature [4]. Based on five easily definable maternal characteristics, the Robson-10 classification system (RTGCS) introduced in 2001 and recognized by the WHO as the global standard for the analysis of pregnant patients [23], minimizes bias by comparing pregnant populations both within and across insitutions [24]. Using the propensity score matching method the present study aimed to analyse the impact of EA on the length of the second stage of labour and on foetal and maternal outcomes in the population of pregnant women referred to an Italian university hospital. These women have been stratified according to the RTGCS in order to settle the maternal characteristic confounders. METHODS A retrospective cohort analysis was performed at a tertiary university hospital over an 11-year period (October 2008 to October 2019). This population was divided according to the RTGCS. Pregnant patients were enrolled according to the following RTGCS groups: R1 (nulliparous, single cephalic full-term pregnancy with spontaneous labour); R2a (nulliparous, single cephalic full-term pregnancy with induced labour); R3 (multiparous, single cephalic full-term pregnancy with spontaneous labour); and R4a (multiparous, single cephalic full-term pregnancy with induced labour). The exclusion criteria for this study were cases involving: multiple pregnancies, known major fetal or chromosomal abnormalities, pre-labour Caesarean deliveries, and elective Caesarean deliveries. All maternal and obstetrical data were prospectively collected by labour and delivery unit personnel by entering cases into a perinatal database, which were then cross tabulated on an Excel file. The collected data included the demographic and obstetric parameters: maternal age and BMI, hypertension, diabetes, foetal weight and position, gestational age, labour induction (intravaginal or intracervical prostaglandin E2 gel, oxytocin), operative vaginal delivery (OVD) (only via the Kiwi OmniCup [produced by Clinical Innovations, Muray, Utah, USA] vacuum extractor), Caesarean section (CS), maternal morbidity (uterine atony, episiotomy, 3rd to 4th degree perineal laceration), and foetal morbidity (Apgar score< 7 at 1 and 5 minutes, neonatal resuscitation). Access to EA is active on a 24-hour basis, with protocols reserving its administration for consenting women previously informed in an epidural outpatient clinic. All women who request analgesia for pain relief during labour are evaluated by an anaesthetist for suitability. Patients meeting absolute (i.e. uncorrected hypovolemia, coagulopathy, anticoagulant therapy) or relative (i.e. anatomical deformities, certain neurological disorders, sepsis) exclusion criteria are not qualified to receive EA. During labour, in the presence of a cervical dilatation of ≥3cm and in the active phase of the first stage (established by partograph), maternal status (blood pressure and temperature), and foetal well-being (20 minutes of normal cardiotocography) are also evaluated. In the absence of abnormalities, intravenous access by a 14-gauge (G) or 16G cannula is positioned and a crystalloid infusion is started. Using an aseptic technique while the patient is in sitting position, an epidural catheter is then placed at the L2-L3 or L3-L4 interspace. Finally, analgesia is established with the epidural administration of a low dose of local anaesthetic, plus a lipid-soluble opioid (ropivacaine 0.1% and sufentanyl 0.5%, 20 mL). Maternal blood pressure, foetal heart rate, pain scores, and the extent of sensory block are then assessed at five-minute intervals for the first 15 minutes, then at every half-hour. Analgesia is maintained with a top-up regimen, using intermittent manual epidural boluses of increasing concentrations of ropivacaine, with up to 0.15% at full dilation, according to specific needs of individual participants. Statistical analysis As the use of observational data prevents the control of treatment assignment through randomization, systematic differences may be present between treated and untreated subjects in an randomized controlled trial. This can introduce confounding and thus prevent associations from being reliably estimated. However, the propensity score method is a statistical technique that aims to predict the probability of receiving treatment and/or having a condition based on identified covariates and background characteristics. Thus, the study population has been matched using a propensity score model with the optimal algorithm, including maternal age, BMI, gestational age, neonatal weight, parity, diabetes, and hypertension. The algorithm excluded patients with missing data in the matching variables. The quality of the matching was verified by considering an acceptable standard mean difference of <0.1 that was obtained in all participant groups. Data have been reported by mean ± standard deviation or by rate (i.e. percentage), unless indicated otherwise. All numerical variables with normal distributions were compared with t-tests, while categorical variables were compared with the chi-squared test or Fisher test when expected frequencies were less than 5. Statistical significance was considered for p-values <0.05. All analyses were performed in the R-statistical computing software 4.1.


Recruitment information / eligibility

Status Completed
Enrollment 21808
Est. completion date September 1, 2021
Est. primary completion date July 1, 2021
Accepts healthy volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - pregnant women, - at term (37-42 weeks), - admitted to a tertiary university hospital over an 11-year period (October 2008 to October 2019) Exclusion Criteria: - multiple pregnancies, - known major fetal or chromosomal abnormalities, - pre-labour Caesarean deliveries, - elective Caesarean deliveries.

Study Design


Intervention

Procedure:
Epidural Analgesia
Using an aseptic technique while the patient is in sitting position, an epidural catheter was placed at the L2-L3 or L3-L4 interspace. Analgesia was established with the epidural administration of a low dose of local anaesthetic, plus a lipid-soluble opioid (ropivacaine 0.1% and sufentanyl 0.5%, 20 mL). Analgesia was maintained with a top-up regimen, using intermittent manual epidural boluses of increasing concentrations of ropivacaine, with up to 0.15% at full dilation, according to specific needs of individual participants.

Locations

Country Name City State
Italy IRCCS Policlinico Agostino Gemelli Rome

Sponsors (1)

Lead Sponsor Collaborator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Country where clinical trial is conducted

Italy, 

References & Publications (33)

ACOG Committee Opinion No. 766: Approaches to Limit Intervention During Labor and Birth. Obstet Gynecol. 2019 Feb;133(2):e164-e173. doi: 10.1097/AOG.0000000000003074. — View Citation

Anim-Somuah M, Smyth RM, Cyna AM, Cuthbert A. Epidural versus non-epidural or no analgesia for pain management in labour. Cochrane Database Syst Rev. 2018 May 21;5:CD000331. doi: 10.1002/14651858.CD000331.pub4. Review. — View Citation

Antonakou A, Papoutsis D. The Effect of Epidural Analgesia on the Delivery Outcome of Induced Labour: A Retrospective Case Series. Obstet Gynecol Int. 2016;2016:5740534. Epub 2016 Nov 20. — View Citation

Bannister-Tyrrell M, Ford JB, Morris JM, Roberts CL. Epidural analgesia in labour and risk of caesarean delivery. Paediatr Perinat Epidemiol. 2014 Sep;28(5):400-11. doi: 10.1111/ppe.12139. Epub 2014 Jul 18. — View Citation

Betran AP, Torloni MR, Zhang JJ, Gülmezoglu AM; WHO Working Group on Caesarean Section. WHO Statement on Caesarean Section Rates. BJOG. 2016 Apr;123(5):667-70. doi: 10.1111/1471-0528.13526. Epub 2015 Jul 22. — View Citation

Bregand-White JM, Kominiarek M, Hibbard JU Consortium On Safe L. OS030. Hypertension and labor duration: Does it take longer? Pregnancy Hypertens. 2012 Jul;2(3):192. doi: 10.1016/j.preghy.2012.04.031. Epub 2012 Jun 13. — View Citation

Carlhäll S, Källén K, Blomberg M. Maternal body mass index and duration of labor. Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):49-53. doi: 10.1016/j.ejogrb.2013.08.021. Epub 2013 Aug 29. — View Citation

Cheng YW, Hopkins LM, Laros RK Jr, Caughey AB. Duration of the second stage of labor in multiparous women: maternal and neonatal outcomes. Am J Obstet Gynecol. 2007 Jun;196(6):585.e1-6. — View Citation

Cheng YW, Shaffer BL, Nicholson JM, Caughey AB. Second stage of labor and epidural use: a larger effect than previously suggested. Obstet Gynecol. 2014 Mar;123(3):527-535. doi: 10.1097/AOG.0000000000000134. Erratum in: Obstet Gynecol. 2014 May;123(5):1109 — View Citation

de Barros Duarte L, Moisés EC, Carvalho Cavalli R, Lanchote VL, Duarte G, da Cunha SP. Distribution of fentanyl in the placental intervillous space and in the different maternal and fetal compartments in term pregnant women. Eur J Clin Pharmacol. 2009 Aug — View Citation

Fritel X, Schaal JP, Fauconnier A, Bertrand V, Levet C, Pigné A. Pelvic floor disorders 4 years after first delivery: a comparative study of restrictive versus systematic episiotomy. BJOG. 2008 Jan;115(2):247-52. Epub 2007 Oct 25. — View Citation

Ghi T, Maroni E, Youssef A, Morselli-Labate AM, Paccapelo A, Montaguti E, Rizzo N, Pilu G. Sonographic pattern of fetal head descent: relationship with duration of active second stage of labor and occiput position at delivery. Ultrasound Obstet Gynecol. 2 — View Citation

Gimovsky AC, Berghella V. Randomized controlled trial of prolonged second stage: extending the time limit vs usual guidelines. Am J Obstet Gynecol. 2016 Mar;214(3):361.e1-6. doi: 10.1016/j.ajog.2015.12.042. — View Citation

Gimovsky AC, Guarente J, Berghella V. Prolonged second stage in nulliparous with epidurals: a systematic review. J Matern Fetal Neonatal Med. 2017 Feb;30(4):461-465. Epub 2016 May 5. Review. — View Citation

La Camera G, La Via L, Murabito P, Pitino S, Dezio V, Interlandi A, Minardi C, Astuto M. Epidural analgesia during labour and stress markers in the newborn. J Obstet Gynaecol. 2021 Jul;41(5):690-692. doi: 10.1080/01443615.2020.1755621. Epub 2020 Jun 4. — View Citation

Laughon SK, Berghella V, Reddy UM, Sundaram R, Lu Z, Hoffman MK. Neonatal and maternal outcomes with prolonged second stage of labor. Obstet Gynecol. 2014 Jul;124(1):57-67. doi: 10.1097/AOG.0000000000000278. Erratum in: Obstet Gynecol. 2014 Oct;124(4):842 — View Citation

Moraloglu O, Kansu-Celik H, Tasci Y, Karakaya BK, Yilmaz Y, Cakir E, Yakut HI. The influence of different maternal pushing positions on birth outcomes at the second stage of labor in nulliparous women. J Matern Fetal Neonatal Med. 2017 Jan;30(2):245-249. — View Citation

Naito Y, Ida M, Yamamoto R, Tachibana K, Kinouchi K. The effect of labor epidural analgesia on labor, delivery, and neonatal outcomes: a propensity score-matched analysis in a single Japanese institute. JA Clin Rep. 2019 Jun 18;5(1):40. doi: 10.1186/s4098 — View Citation

O'Connell MP, Hussain J, Maclennan FA, Lindow SW. Factors associated with a prolonged second state of labour--a case-controlled study of 364 nulliparous labours. J Obstet Gynaecol. 2003 May;23(3):255-7. — View Citation

Obstetric care consensus no. 1: safe prevention of the primary cesarean delivery. Obstet Gynecol. 2014 Mar;123(3):693-711. doi: 10.1097/01.AOG.0000444441.04111.1d. — View Citation

Ravelli ACJ, Eskes M, de Groot CJM, Abu-Hanna A, van der Post JAM. Intrapartum epidural analgesia and low Apgar score among singleton infants born at term: A propensity score matched study. Acta Obstet Gynecol Scand. 2020 Sep;99(9):1155-1162. doi: 10.1111 — View Citation

Robson MS. Can we reduce the caesarean section rate? Best Pract Res Clin Obstet Gynaecol. 2001 Feb;15(1):179-94. — View Citation

Shen X, Li Y, Xu S, Wang N, Fan S, Qin X, Zhou C, Hess PE. Epidural Analgesia During the Second Stage of Labor: A Randomized Controlled Trial. Obstet Gynecol. 2017 Nov;130(5):1097-1103. doi: 10.1097/AOG.0000000000002306. — View Citation

Shmueli A, Salman L, Orbach-Zinger S, Aviram A, Hiersch L, Chen R, Gabbay-Benziv R. The impact of epidural analgesia on the duration of the second stage of labor. Birth. 2018 Dec;45(4):377-384. doi: 10.1111/birt.12355. Epub 2018 May 22. — View Citation

Simic M, Cnattingius S, Petersson G, Sandström A, Stephansson O. Duration of second stage of labor and instrumental delivery as risk factors for severe perineal lacerations: population-based study. BMC Pregnancy Childbirth. 2017 Feb 21;17(1):72. doi: 10.1 — View Citation

Srebnik N, Barkan O, Rottenstreich M, Ioscovich A, Farkash R, Rotshenker-Olshinka K, Samueloff A, Grisaru-Granovsky S. The impact of epidural analgesia on the mode of delivery in nulliparous women that attain the second stage of labor. J Matern Fetal Neon — View Citation

Wang Q, Zheng SX, Ni YF, Lu YY, Zhang B, Lian QQ, Hu MP. The effect of labor epidural analgesia on maternal-fetal outcomes: a retrospective cohort study. Arch Gynecol Obstet. 2018 Jul;298(1):89-96. doi: 10.1007/s00404-018-4777-6. Epub 2018 May 18. — View Citation

Wang TT, Sun S, Huang SQ. Effects of Epidural Labor Analgesia With Low Concentrations of Local Anesthetics on Obstetric Outcomes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesth Analg. 2017 May;124(5):1571-1580. doi: 10.1213/ — View Citation

Webb DA, Culhane J. Hospital variation in episiotomy use and the risk of perineal trauma during childbirth. Birth. 2002 Jun;29(2):132-6. — View Citation

Ye Y, Song X, Liu L, Shi SQ, Garfield RE, Zhang G, Liu H. Effects of Patient-Controlled Epidural Analgesia on Uterine Electromyography During Spontaneous Onset of Labor in Term Nulliparous Women. Reprod Sci. 2015 Nov;22(11):1350-7. doi: 10.1177/1933719115578926. Epub 2015 Mar 29. — View Citation

Zha Y, Gong X, Yang C, Deng D, Feng L, Luo A, Wan L, Qiao F, Zeng W, Chen S, Wu Y, Han D, Liu H. Epidural analgesia during labor and its optimal initiation time-points: A real-world study on 400 Chinese nulliparas. Medicine (Baltimore). 2021 Mar 5;100(9): — View Citation

Zhang J, Landy HJ, Ware Branch D, Burkman R, Haberman S, Gregory KD, Hatjis CG, Ramirez MM, Bailit JL, Gonzalez-Quintero VH, Hibbard JU, Hoffman MK, Kominiarek M, Learman LA, Van Veldhuisen P, Troendle J, Reddy UM; Consortium on Safe Labor. Contemporary p — View Citation

Zhang L, Xu C, Li Y. Impact of epidural labor analgesia using sufentanil combined with low-concentration ropivacaine on maternal and neonatal outcomes: a retrospective cohort study. BMC Anesthesiol. 2021 Sep 22;21(1):229. doi: 10.1186/s12871-021-01450-2. — View Citation

* Note: There are 33 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Lenght of 2nd stage Evaluate the length of the second stage of labour From the time of the first documented full cervical dilatation to delivery
Secondary Foetal Outcome Foetal outcome measured as Apgar's score At 1 and 5 minutes after birth
Secondary maternal outcome Incidence of uterine atony, 3rd and 4th degree lacerations, episiotomy, cesarean section and operative vaginal delivery. 2 hours after the delivery.
See also
  Status Clinical Trial Phase
Completed NCT03539562 - Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep
Withdrawn NCT04662450 - Evaluation and Management of Parturients' Pain Intensity N/A
Completed NCT02885350 - Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour Phase 4
Completed NCT02550262 - Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor N/A
Completed NCT01598506 - Intrathecal Hydromorphone for Labor Analgesia Phase 2
Withdrawn NCT01636999 - Comparing Sedara to Butorphanol in Early Labor N/A
Completed NCT00987441 - Epidural Labor Analgesia and Infant Neurobehavior N/A
Completed NCT00755092 - Effect of Doula in Nulliparas and Multiparas N/A
Terminated NCT00787176 - The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes N/A
Recruiting NCT06036797 - Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia Phase 2
Completed NCT05512065 - Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women N/A
Completed NCT05327088 - Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia Phase 2
Completed NCT03103100 - Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation Phase 3
Recruiting NCT03623256 - Comparison of Intrathecal Versus Epidural Fentanyl on Fetal Bradycardia in Labor Combined Spinal Epidural Analgesia Phase 4
Active, not recruiting NCT02271100 - Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique N/A
Completed NCT02926469 - Virtual Reality Analgesia in Labor: The VRAIL Pilot Study N/A
Completed NCT03712735 - Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women Phase 4
Not yet recruiting NCT05565274 - Outcome of Combined Tramadol and Paracetamol Versus Pentazocine as Labour Analgesia Among Parturients N/A
Recruiting NCT01708668 - The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia N/A
Recruiting NCT02575677 - Oxycodone in Treatment of Early Labour Pain Efficacy and Safety